Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy - Mok, T; Wu, Y L; Lee, J S (Clin Cancer Res, 2015)
, et al.